In our cohort, DNMT1 and DNMT3B do not show different methylation levels among different tissues, so we cannot hypothesize the involvement of the methylation of these genes in thymoma-associated myasthenia gravis pathogenesis. The gene discussed is DNMT3B; the disease is thymoma.